COMMUNIQUÉS West-GlobeNewswire

Financière de Tubize SA : Cancellation of own shares - New denominator
31/01/2019
Press release 31st January 2019 - 8:00h CET FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, general manager, aspijcke@icloud.com Cancellation of own shares New denominator [...]
Financière de Tubize SA : Annulation d'actions propres - Nouveau dénominateur
31/01/2019
Communiqué de presse 31 janvier 2019 - 8:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: Anne Sophie Pijcke, aspijcke@icloud.com Annulation d'actions propres Nouveau dénominateur [...]
Deinove is preparing initiation of Phase II for DNV3837 in Clostridium difficile infections, with a key partner
31/01/2019
Deinove is preparing initiation of Phase II for DNV3837 in Clostridium difficile infections, with a key partner The test design has been improved for a better assessment of DNV3837 effectiveness in treating Clostridium [...]
DEINOVE prépare l’entrée en Phase II du DNV3837 dans les infections à Clostridium difficile avec un partenaire-clé
31/01/2019
DEINOVE prépare l’entrée en Phase II du DNV3837 dans les infections à Clostridium difficile avec un partenaire-clé Le design de l’essai a été optimisé pour maximiser les chances de démontrer l’efficacité du DNV3837 dans [...]
Aladote®’s data has been selected for presentation at The International Liver Congress
31/01/2019
Stockholm, January 31, 2019. PledPharma AB (publ) announces that the abstract on the positive results from the Aladote ® ’s Phase Ib/IIa proof of principle-study has been selected for an oral presentation at the global [...]
Plan Stratégique Newway 2021
31/01/2019
NEWWAY 2021 Positionner Spineway comme acteur international de référence en mini-invasif Nouvelle politique commerciale Evolution des gammes de produits Partenariats stratégiques ciblés Spineway, spécialiste des [...]
Ambu A/S: Interim Report for Q1 2018/19
31/01/2019
In Q1, Ambu realised organic growth of 15% and a 43% increase in sales of endoscopes to 149,000 units. Gross profit increased by 1.9 percentage points to 59.9%, resulting in an EBIT margin of 17.1%. " In Q1, we have [...]
VALNEVA Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate
31/01/2019
Valneva Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate Saint-Herblain (France), January 31, 2019 - Valneva SE ("Valneva"), a biotech company developing and [...]
VALNEVA : résultats positifs pour la première évaluation de la dose de rappel du vaccin contre la maladie de Lyme et les données finales de l'étude de Phase 1
31/01/2019
Valneva : résultats positifs pour la première évaluation de la dose de rappel du vaccin contre la maladie de Lyme et les données finales de l'étude de Phase 1 Saint-Herblain (France), 31 janvier 2019 - Valneva SE (" [...]
Novan Provides Business Update
30/01/2019
End-of-Phase 2 meeting with FDA for molluscum granted and scheduled for early March Active business development discussions ongoing around certain late-stage assets and broader dermatology platform Dr. David Hebert [...]
aTyr Pharma Announces Research Collaboration with the University of Nebraska Medical Center and Expansion of Successful Pilot Study
30/01/2019
Collaboration to advance neuropilin-2 biology and explore potential therapeutic opportunities for ATYR1923 Reinforces aTyr’s commitment to working with a strategic network of leading academic collaborators SAN DIEGO, [...]
Major shareholder announcement
30/01/2019
Orphazyme A/S Company announcement No. 02/2019 Company Registration No. 32266355 Copenhagen, January 30, 2019 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]
Genesis HealthCare Recognized as a We Honor Veterans Community Partner
30/01/2019
KENNETT SQUARE, Pa., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Veterans often carry experiences from their military service that present unique healthcare challenges, and unfortunately, many of them may not know about, or have [...]
DLT Resolution Divests A.J.D Data, Strengthens Balance Sheet and Expands Secure Data Services
30/01/2019
Las Vegas, NV, Jan. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) Data Management and Information Technology company, is pleased to [...]
Is Too Much Exercise Dangerous?
30/01/2019
Study shows that extreme exercise does not increase risk of death from heart disease DALLAS, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Athletes come in all forms, from the professional athlete to the everyday runner. We know [...]
Sienna Announces Fourth Quarter 2018 Results Release Date and Conference Call - Date Change
30/01/2019
MARKHAM, Ontario, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced that it has moved up the date for when it will report its 2018 fourth quarter results. [...]
Medtronic Valiant(TM) Captivia(TM) Demonstrates Durability, Safety, and Efficacy at Five Years in Transection Patients
30/01/2019
New RESCUE Trial Data Presented in Blunt Thoracic Aortic Injury DUBLIN and SAN DIEGO - January 30, 2019 - Medtronic plc (NYSE:MDT) today announced new data supporting the long-term durability, safety, and efficacy of [...]
HEXO Corp. closes C$57.5 million public offering of common shares
30/01/2019
GATINEAU, Quebec, Jan. 30, 2019 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO ; NYSE-A: HEXO ) is pleased to announce the closing of its previously announced marketed offering of 8,855,000 common [...]
HEXO Corp annonce la clôture de son offre publique d’actions ordinaires de 57,5 M $ CA
30/01/2019
GATINEAU, Québec, 30 janv. 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO ; NYSE-A: HEXO ) a le plaisir d’annoncer la clôture de son placement négocié annoncé précédemment de 8 855 000 [...]

Pages